Development of a Novel Zolmitriptan Intracutaneous Microneedle System (Qtrypta™) for the Acute Treatment of Migraine

References

• Gilmore B , MichaelM. Treatment of acute migraine headache. Am. Fam. Physician83(3), 271–280 (2011).
   PubMed Web of Science ®Google Scholar
• Marmura MJ , SilbersteinSD , SchwedtTJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache55(1),3–20 (2015).
   PubMed Web of Science ®Google Scholar
• Ferrari MD , GoadsbyPJ , RoonKI , LiptonRB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia22(8),633–658 (2002).
   PubMed Web of Science ®Google Scholar
• Kelman L . Review of frovatriptan in the treatment of migraine. Neuropsychiatr. Dis. Treat.4(1),49–54 (2008).
   PubMedGoogle Scholar
• Ashcroft DM , MillsonD. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Pharmacoepidemiol. Drug Safe.13(2),73–82 (2004).
   PubMed Web of Science ®Google Scholar
• Brandes JL , KudrowD , CadyR , TiseoPJ , SunW , SikesCR. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. Cephalalgia25(9),735–742 (2005).
   PubMed Web of Science ®Google Scholar
• Cady RK , SheftellF , LiptonRBet.al Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin. Ther.22(9),1035–1048 (2000).
   PubMed Web of Science ®Google Scholar
• Freitag FG , FinlaysonG , RapoportAMet.al Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg time versus intensity migraine study (AIMS). Headache47(4),519–530 (2007).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ , ZanchinG , GeraudGet.al Early vs. non-early intervention in acute migraine – ‘act when mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia28(4),383–391 (2008).
   PubMed Web of Science ®Google Scholar
• Hu XH , RaskinNH , CowanR , MarksonLE , BergerML. Treatment of migraine with rizatriptan: when to take the medication. Headache42(1),16–20 (2002).
   PubMed Web of Science ®Google Scholar
• Lanteri-Minet M , MickG , AllafB. Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study. Cephalalgia32(3),226–235 (2012).
   PubMed Web of Science ®Google Scholar
• Mathew NT , FinlaysonG , SmithTRet.al Early intervention with almotriptan: results of the AEGIS trial (AXERT early migraine intervention study). Headache47(2),189–198 (2007).
   PubMed Web of Science ®Google Scholar
• Schoenen J . When should triptans be taken during a migraine attack?CNS drugs15(8),583–587 (2001).
   PubMed Web of Science ®Google Scholar
• Dahlof CG . Non-oral formulations of triptans and their use in acute migraine. Curr. Pain Headache Rep.9(3),206–212 (2005).
   PubMedGoogle Scholar
• Dodick D , SilbersteinS. Central sensitization theory of migraine: clinical implications. Headache46(Suppl. 4), S182–S191 (2006).
   PubMed Web of Science ®Google Scholar
• Tepper SJ , KoriSH , MathewNTet.al Efficacy evaluation of LEVADEX (previously MAP0004) in treating resistant migraine including migraine with allodynia, migraine treated late in its cycle, morning migraine and disabling migraine. Presented at: The International Headache Congress.PA, USA (2009).
   Google Scholar
• Kellerman DJ , AmeriM , TepperSJ. Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray. Pain Manag.7(6),559–567 (2017).
   PubMedGoogle Scholar
• Ameri M , DaddonaPE , MaaYF. Demonstrated solid-state stability of parathyroid hormone PTH(1–34) coated on a novel transdermal microprojection delivery system. Pharm. Res.26(11),2454–2463 (2009).
   PubMed Web of Science ®Google Scholar
• Cosman F , LaneNE , BologneseMAet.al Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J. Clin. Endocrinol. Metab.95(1),151–158 (2010).
   PubMed Web of Science ®Google Scholar
• Daddona PE , MatrianoJA , MandemaJ , MaaYF. Parathyroid hormone (1–34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res.28(1),159–165 (2011).
   PubMed Web of Science ®Google Scholar
• Palylyk-Colwell E , FordC. Transdermal glucagon patch for severe hypoglycemia. https://www.ncbi.nlm.nih.gov/books/NBK481476/
   Google Scholar
• Nguyen J , LewisH , QuejaA , DiepAN , HochartG , AmeriM. Pharmacokinetics and skin tolerability of intracutaneous zolmitriptan delivery in swine using adhesive dermally applied microarray. J. Pharm. Sci.107(8),2192–2197 (2018).
   PubMed Web of Science ®Google Scholar
• Spierings EL , BrandesJL , KudrowDBet.al Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine. Cephalalgia38(2),215–224 (2018).
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation and Research . Migraine: developing drugs for acute treatment guidance for industry. https://www.fda.gov/downloads/drugs/guidances/ucm419465.pdf
   Google Scholar
• Tepper SJ , DodickDW , SchmidtPC , KellermanDJ. Efficacy of ADAM zolmitriptan for the acute treatment of difficult-to-treat migraine headaches. Headache59(4),509–517 (2019).
   PubMed Web of Science ®Google Scholar
• Dowson AJ , TepperSJ , BaosV , BaudetF , D’AmicoD , KilminsterS. Identifying patients who require a change in their current acute migraine treatment: the migraine assessment of current therapy (Migraine-ACT) questionnaire. Curr. Med. Res. Opin.20(7),1125–1135 (2004).
   PubMed Web of Science ®Google Scholar
• Kilminster SG , DowsonAJ , TepperSJ , BaosV , BaudetF , D’AmicoD. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire. Headache46(4),553–562 (2006).
   PubMed Web of Science ®Google Scholar
• Tepper S , KudrowD , SpieringsEet.al Assessing the long-term effectiveness of Qtrypta® using Migraine-ACT: correlation with e-Diary. 61st Annual Scientific Meeting of the American Headache Society.PA USA (11–14 July 2019).
   Google Scholar